Mirae Asset Global Etfs Holdings Ltd. Tango Therapeutics, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 41,998 shares of TNGX stock, worth $325,904. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,998
Previous 28,638
46.65%
Holding current value
$325,904
Previous $39,000
451.28%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding TNGX
# of Institutions
123Shares Held
117MCall Options Held
245KPut Options Held
18.9K-
Trv Gp Iv, LLC Boston, MA16.9MShares$131 Million97.21% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$83.3 Million11.21% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$82.5 Million4.69% of portfolio
-
Farallon Capital Management LLC San Francisco, CA9.16MShares$71.1 Million0.21% of portfolio
-
Woodline Partners LP San Francisco, CA6.03MShares$46.8 Million0.18% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $683M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...